We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Ebola vaccines

News List

GSK transfers rights to Ebola vaccines development to US institute pharmaceutical-technology
August 08, 2019
Drug manufacturer GlaxoSmithKline (GSK) transfers its rights to advance the development of the deadly Ebola Zaire, Ebola Sudan and Marburg virus vaccines to the Sabin Vaccine Institute in the US.
Ebola vaccines from GSK, Merck elicit yearlong response, study finds fiercepharma
October 16, 2017
After initially setting out to test two vaccines on 28,000 volunteers during West Africa's deadly Ebola epidemic, a U.S.-Liberia research team had to dramatically reduce its aspirations when the outbreak started coming to an end.
Ebola vaccines in a trial elicit immune response for a year long europeanpharmaceuticalreview
October 16, 2017
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year…